- Country: USA
- Summary: New Therapeutic Strategies For Genital Herpes (R21/R33 Clinical Trial Not Allowed)
- UST Ref No: 108733563
- Deadline: 31 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-AI-24-068
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Purpose Of This Notice Of Funding Opportunity (Nofo) Is To Stimulate The Development Of New Treatments For Genital Herpes That Suppress Shedding And Lesion Formation And Reduce Transmission. This Nofo Invites Applications That Propose Research Into A Broad Range Of Therapeutic Approaches, Including But Not Limited To Development Of New Or Improved Antivirals, Monoclonal Antibodies, Therapeutic Vaccines, And Gene Editing Technologies For Treatment Of Patients Living With Genital Herpes. This Nofo Will Use A Milestone-Driven, Biphasic Award Mechanism. Transition To The Second Phase Is Not Guaranteed And Will Depend On The Successful Completion Of Milestones.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNew Therapeutic Strategies For Genital Herpes (R21/R33 Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for New Therapeutic Strategies For Genital Herpes (R21/R33 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 108733563 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
